This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations of Yun Ju Kwon in Antifungal Research
Introduction
Yun Ju Kwon is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of bioscience and biotechnology, particularly in the development of antifungal compositions. His work focuses on addressing the challenges posed by antibiotic-resistant microbes.
Latest Patents
Yun Ju Kwon holds a patent for an "Antifungal composition comprising polycyclic peptide compound and method for preparing the same." This patent discloses a novel strain with antibacterial activity, identified as sp. AN1542 strain (Accession No.: KCTC 12113BP). The antibacterial composition includes a compound represented by Chemical Formula 1 or 2, or a strain producing the same as an active ingredient. This invention exhibits potent antibacterial activity against pathogenic microbes and antibiotic-resistant microbes, particularly MRSA, QRSA, VRSA, and VRE. The compound or strain can be applied to the treatment of infectious diseases caused by superbacteria.
Career Highlights
Yun Ju Kwon is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His research has led to advancements in the development of effective treatments for infections caused by resistant strains of bacteria. His innovative approach has garnered attention in the scientific community.
Collaborations
Yun Ju Kwon collaborates with esteemed colleagues, including Won Gon Kim and Mi Jin Sohn. Their combined expertise contributes to the ongoing research and development in the field of bioscience.
Conclusion
Yun Ju Kwon's work in antifungal research exemplifies the importance of innovation in combating antibiotic resistance. His contributions are vital for the advancement of medical treatments and the fight against superbacteria.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
